Skip to main content

Table 1 Concordance table urine biomarker test versus ERSPC R4

From: Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports

Previous Negative Biopsy Cohort

ERSPC R4 (+)

ERSPC R4 (−)

Total

SelectMDx test (+)

5

15

20

SelectMDx test (−)

0

14

14

Total

5

29

34